8-KFiled Sep 24, 8:00 PM ET

Catheter Precision to Become Flyte Aviation; 1-for-10 Reverse Split

$VTAK · Catheter Precision, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Catheter Precision to Become Flyte Aviation; 1-for-10 Reverse Split

What Happened

  • Catheter Precision, Inc. filed an 8-K on Sept. 25, 2026 announcing that its Board approved an amendment to its certificate of incorporation to change the company name to Flyte Aviation, Inc. and to effect a 1-for-10 reverse split of its common stock. The changes are expected to become effective at 12:01 a.m. ET on October 5, 2026. The reverse split ratio (1-for-10) was selected by the Board within a range previously approved by stockholders at a special meeting on April 15, 2026.

Key Details

  • Effective time: 12:01 a.m. Eastern Time on October 5, 2026.
  • Ticker and trading: Common stock expected to trade on NYSE American under the new name "Flyte Aviation, Inc." and new ticker symbol VJET at the open on Oct. 5, 2026 (current ticker VTAK).
  • Fractional shares: No fractional shares will be issued; holders entitled to fractions will receive a pro rata cash payment from sale of aggregated fractional shares by the exchange agent.
  • Corporate mechanics: Reverse split does not change par value or number of authorized shares; outstanding equity awards, warrants and convertible securities will be adjusted in accordance with their terms. New CUSIP after split: 74933X 807.

Why It Matters

  • For investors, the actions are corporate housekeeping that change ticker/name and reduce the number of outstanding shares via a 1-for-10 reverse split. The split will increase the per-share price mechanically but does not change each holder’s proportional ownership (except for cash-outs of fractional shares). Expect the stock to begin trading on a split-adjusted basis and under the new name and ticker at market open on Oct. 5, 2026.